The government is likely to ban more fixed dose combinations (FDCs) this month. An expert committee found that these FDCs lack therapeutic justification and may pose risks to humans. This follows earlier bans on 156 FDCs, including antibiotics and painkillers, for similar reasons. The decision is based on recommendations from the Drug Technical Advisory Board.
